Medical Center Hera EOOD
- Address
- Ulitsa Tsar Boris Treti 11a, Fl 2, 3400 Montana, Bulgaria
Medical Center Hera EOOD - Specialized Research in Neurological, Respiratory, and Infectious Diseases
Medical Center Hera EOOD is a clinical research facility with expertise in conducting complex Phase 1-3 studies across multiple therapeutic areas. The center demonstrates particular strength in biosimilar comparability studies, vaccine efficacy trials, and long-term safety evaluations, supporting the development of innovative treatments for chronic and infectious diseases.
- Multiple Sclerosis and Neurological Disorders - Pharmacokinetic and efficacy studies of biosimilar therapeutics
- Influenza Prevention - Large-scale vaccine efficacy trials in elderly populations
- Bronchiectasis Management - Long-term safety and treatment continuation studies
The center's research portfolio reflects a commitment to advancing treatment options for patients with relapsing-remitting multiple sclerosis, demonstrating expertise in complex biosimilar development programs including pharmacokinetic, pharmacodynamic, and efficacy comparisons. Their involvement in vaccine research focuses on adjuvanted influenza vaccines for vulnerable adult populations aged 65 and older. Additionally, Medical Center Hera EOOD contributes to understanding long-term treatment outcomes in chronic respiratory conditions, participating in extension studies that evaluate the sustained safety profile of novel therapeutic agents for bronchiectasis.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 476 other sites in Bulgaria
Therapeutic Area Benchmark — Bulgaria
Select a therapeutic area to compare against other sites in Bulgaria.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Bulgaria
Market Share
Country: Bulgaria
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Medical Center Hera EOOD
lock Showing 1 of 4 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Double-blind, Randomized, Active-controlled, Parallel-group, Phase 1/3 study to Compare Efficacy, Pharmacokinetics, Pharmacodynamics and Safety of CT-P53 and Ocrevus in Patients with Relapsing-remitting Multiple Sclerosis. | Celltrion Inc. | Phase III | Not Recruiting | Jan 2024 | — |
IMP list
lock Showing 1 of 13 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| A/DARWIN/9/2021 (H3N2) - LIKE STRAIN (A/DARWIN/6/2021, IVR-227) | 1 | Unknown | 2023-10-20 | 2023-10-20 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.